辛伐他汀对冠心病心衰患者超敏C反应蛋白的影响

Effects of simvastatin on high - sensitivity C - reactive protein in the patients with heart failure of CHD

目的观察辛伐他汀对冠心病心衰患者血清超敏C反应蛋白（hs—CRP）的影响，并观察心血管事件的发生情况。方法将慢性心衰患者82例随机分为治疗组与对照组，两组均按慢性心力衰竭治疗指南给予常规治疗，治疗组另外服用辛伐他汀，两组治疗前后检查血清超敏C反应蛋白并观察其心血管事件的发生率。结果6个月后，治疗组hs—CRP与对照组比较明显降低，心血管事件发生率低。结论辛伐他汀可降低hs—CRP水平，减少心血管事件的发生。

Objective To observe the c Effects of Simvastatin on high -sensitivity C -reactive protein in the patients with head failure of CFID, and the incidence of cardiovascular events. Methods 82 patients with CHF were rando mLy divided into treated group and control group, which were given usual treatment according to the guide of CHF treatment. Meanwhile, Simvastatin was added to the treated group. Two groups need to detected the hs - CRP before and after treatment,and both the incidence of cardiovascular events. Results After 6 months,compared to the control group, the hs - CRP of the treated group decreased in varying degred, the incidence of cardiovascular events was lower. Conclusion Simvastatin can decrease the hs - CRP and the incidence of cardiovascular events.